Caries-preventing effect of a hydroxyapatite-toothpaste in adults: a 18-month double-blinded randomized clinical trial

Front Public Health. 2023 Jul 18:11:1199728. doi: 10.3389/fpubh.2023.1199728. eCollection 2023.

Abstract

Background: Dental caries is a worldwide challenge for public health. The aim of this 18-month double-blinded, randomized, clinical trial was to compare the caries-preventing effect of a fluoride-free, hydroxyapatite toothpaste (test) and a toothpaste with sodium fluoride (1450 ppm fluoride; positive control) in adults.

Methods: The primary endpoint was the percentage of subjects showing no increase in overall Decayed Missing Filled Surfaces (DMFS) index. The study was designed as non-inferiority trial. Non-inferiority was claimed if the upper limit of the exact one-sided 95% confidence interval for the difference of the primary endpoint DMFS between test and control toothpaste was less than the predefined margin of non-inferiority (Δ ≤ 20%).

Results: In total, 189 adults were included in the intention-to-treat (ITT) analysis; 171 subjects finished the study per protocol (PP). According to the PP analysis, no increase in DMFS index was observed in 89.3% of subjects of the hydroxyapatite group and 87.4% of the subjects of the fluoride group. The hydroxyapatite toothpaste was not statistically inferior to a fluoride toothpaste with regard to the primary endpoint.

Conclusion: Hydroxyapatite was proven to be a safe and efficient anticaries agent in oral care.

Clinical trial registration: NCT04756557.

Keywords: Decayed Missing Filled Surfaces (DMFS) index; adults; dental caries; fluoride; hydroxyapatite; public health; randomized clinical trial (RCT); toothpaste.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cariostatic Agents / therapeutic use
  • Dental Caries Susceptibility
  • Dental Caries* / prevention & control
  • Durapatite
  • Fluorides / therapeutic use
  • Humans
  • Toothpastes* / therapeutic use

Substances

  • Toothpastes
  • Cariostatic Agents
  • Durapatite
  • Fluorides

Associated data

  • ClinicalTrials.gov/NCT04756557

Grants and funding

This research was funded by Dr. Kurt Wolff GmbH & Co. KG, Bielefeld, Germany, and both universities, the Poznan University of Medical Sciences in Poznan and the Medical University in Bialystok, Poland.